KNC Laboratories Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
Revenue	4,612	3,812	4,005	3,806
Revenue Growth (YoY)	20.99%	-4.81%	5.22%	-
Cost of Revenue	3,419	2,900	3,007	2,888
Gross Profit	1,193	911.54	997.46	917.25
Selling, General & Admin	895	-	-	-
Other Operating Expenses	-	621.77	685.73	660.61
Operating Expenses	895	621.77	685.73	682.74
Operating Income	298	289.76	311.74	234.51
Interest Expense	-28	-19.02	-20.45	-20.64
Interest & Investment Income	1	-	-	-
Other Non Operating Income (Expenses)	17	-23.1	60.73	52.02
EBT Excluding Unusual Items	288	247.64	352.02	265.89
Gain (Loss) on Sale of Investments	-17	-	-	-
Gain (Loss) on Sale of Assets	-436	-	-	-
Other Unusual Items	476	-	-	-
Pretax Income	311	247.64	352.02	265.89
Income Tax Expense	-80	65.63	64.04	85.29
Net Income to Company	391	-	-	-
Net Income	391	182.02	287.98	180.6
Net Income to Common	391	182.02	287.98	180.6
Net Income Growth	114.81%	-36.79%	59.45%	-
Shares Outstanding (Basic)	6	-	-	-
Shares Outstanding (Diluted)	6	-	-	-
EPS (Basic)	65.17	-	-	-
EPS (Diluted)	65.17	-	-	-
Dividend Per Share	10.000	-	-	-
Gross Margin	25.87%	23.91%	24.91%	24.10%
Operating Margin	6.46%	7.60%	7.79%	6.16%
Profit Margin	8.48%	4.78%	7.19%	4.75%
EBITDA	-	-	-	256.64
EBITDA Margin	-	-	-	6.74%
EBIT	298	289.76	311.74	234.51
EBIT Margin	6.46%	7.60%	7.79%	6.16%

Source: S&P Capital IQ. Standard template. Financial Sources.